OS Therapies Incorporated (OSTX)
NYSEAMERICAN: OSTX · Real-Time Price · USD
1.710
+0.140 (8.92%)
Mar 9, 2026, 4:00 PM EDT - Market closed
OS Therapies Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 60 | 91 | - | - | - | - |
| Enterprise Value | 58 | 89 | - | - | - | - |
| Last Close Price | 1.71 | 4.28 | - | - | - | - |
| PB Ratio | 15.64 | 112.02 | - | - | - | - |
| Debt / Equity Ratio | - | - | -0.61 | -0.59 | -0.62 | -0.93 |
| Net Debt / Equity Ratio | -0.40 | -6.82 | -0.61 | -0.58 | -0.61 | -0.74 |
| Net Debt / EBITDA Ratio | 0.10 | 0.81 | -3.36 | -2.29 | -1.45 | -0.83 |
| Net Debt / FCF Ratio | 0.15 | 0.76 | -4.85 | -2.68 | -1.58 | -1.93 |
| Quick Ratio | 0.45 | 1.20 | 0.00 | 0.03 | 0.02 | 0.59 |
| Current Ratio | 0.56 | 1.20 | 0.03 | 0.08 | 0.09 | 0.80 |
| Return on Assets (ROA) | -225.11% | -134.41% | -415.27% | -665.62% | -301.75% | - |
| Return on Capital Employed (ROCE) | -409.40% | -747.60% | 18.20% | 78.90% | 152.60% | 1328.40% |
| Earnings Yield | -33.64% | -9.77% | - | - | - | - |
| FCF Yield | -21.39% | -8.01% | - | - | - | - |
| Buyback Yield / Dilution | -481.00% | -127.97% | 45.60% | - | -18.50% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.